Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and previous ...
Symbicort and Advair are similar brand-name prescription medications that treat asthma and COPD. They contain slightly different active ingredients. Symbicort and Advair are two drugs that treat ...
GlaxoSmithKline’s ageing respiratory blockbuster Advair has been living a charmed life since going off patent years ago - but as yet no-one has been able to get a generic rival approved in the key US ...
The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan’s version in three strengths for ages ...
MUMBAI, India, May 19, 2020 /PRNewswire/ -- Cipla Limited ((BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced its submission of an Abbreviated New Drug Application ...
Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus(R) and Insulin Analog to Lantus(R) PITTSBURGH, Sept. 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the ...
RESEARCH TRIANGLE PARK, N.C., Aug. 8 -- GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for ...
The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan’s version in three strengths for ages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback